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Abstract 
Spasticity is a common and complex motor disorder 
that affects more than 12 million persons in the world. 
There are several studies on spasticity quantification in 
the literature but there is still a need for measurement 
improvements. This paper presents the validation, in 
clinical environment, of a mechatronic medical device, 
dedicated, and specially designed and constructed for 
spasticity quantification, in joint of ankle, elbow and 
knees. This approach is based on the velocity-dependent 
of the Stretch Reflex threshold. The relevant variables, 
the measurement range and the adequate measurement 
systems are indicated. The reliability of the developed 
mechatronic medical system is confirmed by data 
acquisition and analysis, following a systematic 
methodology, also presented in the paper. 
1. Introduction 
Spasticity is a complex motor disorder due to a supra-
spinal inhibition, resulting from a hyper-excitability of 
the stretch reflex (SR) [1]. Spasticity affects more than 
12 million persons in the world [2], and is always seen in 
patient with upper motor neuron (UMN) dysfunctions 
such as cerebral vascular accidents, spinal cord injuries, 
and multiple sclerosis. The mechanism of spasticity is 
commonly thought as an exaggerated SR, which is a 
velocity-dependent increase in the resistance to the 
passive movement [3]. The SR Threshold is significantly 
reduced in spastic muscles, and this reduction is 
correlated to the increase in reflex joint torque [4]. 
Spasticity in conjugation with excessive muscle tone 
frequently interferes in the voluntary motor function, 
causing difficulties in daily activities [3]. Some of the 
common symptoms are: a change in the recruitment of 
limb´s segments and a severe mal-functioning of the 
tendons reflex. 
Spasticity is a serious neurological disorder and 
several treatments and therapies have emerged for its 
treatment [5]. The treatment must be appropriate to the 
symptoms presented by each patient and the success of 
treatment is strongly dependent of the selection of 
patients [6]. Therefore, the existence of a sensitive, 
consistent and reproducible method for clinical 
evaluation, of the level of spasticity, plays an important 
role in the selection of patients to access appropriate 
therapies [5], [7].  
Spasticity quantification is a hard and complex task 
[8]. The correct quantification of spasticity has been 
under an extensive study by the scientific community, 
but there is not yet available a well-accepted standard 
method for spasticity determination and quantification. 
The literature presents several methods for spasticity 
quantification: The Ashworth Scale (AS) and the 
Ashworth modified version (MAS); Isokinetic device 
with generator torque; Pendulum Test. None of them is 
fully accepted, due to various reasons [2], [7], [8]. The 
AS and the MAS are the common scales in clinical 
quantifications of spasticity, despite experts agree that 
both scales may not measure the characteristics that 
distinguish spasticity from other tonus disorders. 
Although the scale is useful in determining the amount 
of resistance felt in the passive displacement of the 
limbs, it does not quantify the dependence to velocity of 
SR, which is the feature that differentiates spasticity [7]. 
This scale has a low reproductive rate, a lack of 
validation in all muscle groups, usually affected by 
spasticity [1].  
The approach of traditional measures is based on the 
phase and magnitude of the tonic SR and the resistance 
to passive stretch. Nevertheless, this measure is not 
correlated to the clinical impression of the spasticity 
level, inability to differentiate the mechanical stiffness 
from the reflective stiffness and the implementation of 
the device is still complex; also, the measurement does 
not meet the criteria of the known theory. Hence, there is 
2still a need for a device that meets these requirements 
[1], [7], [8].  
The key issue is to determine which variables are 
necessary to correctly quantify this disorder. A correct 
measure to quantify spasticity must follow the 
physiological mechanisms related to the stand-up 
position control and the movement in healthy individuals 
and/or must detect possible deficiencies in any of these 
mechanisms that lead to motor disorders. For the 
acceptance of the method, their approach must be in 
accordance to a standard spasticity definition [7], [8]. 
The work presented in [9] defined spasticity as: “a motor 
disorder characterized by a velocity-dependent increase 
in tonic stretch reflexes (“muscle tonus”) with 
exaggerated tendon jerk, resulting in hyper excitability 
of the stretch reflexes, as one of the component of the 
upper motor neuron syndrome”. This definition is still 
accepted nowadays; it includes some important aspects: 
it refers to spasticity as a symptom, as a disorder in the 
somatic mobility, related to the high tonic component of 
the SR; it is due to the spinal reflex; it is one of the 
symptoms of the upper motoneuron syndrome; the tonic 
stretch is associated to the exaggerated tendon jerks, and 
reflects the physical component of the SR; the reflex of 
the tone stretch is the basis of the tonus; it is referred that 
the excess of the reflex depends on the stretch velocity 
[10]. This last statement can be the key issue for 
spasticity quantification [2]. 
This paper presents the development of a dedicated 
mechatronic medical device for quantification of all 
levels of spasticity, in joint of ankle, elbow or knees. 
This approach is based on the velocity-dependent of the 
SR threshold. 
2. Proposed approach 
2.1. Device 
The SR is an involuntary contraction elicited by a brief 
stimulus to muscle receptors. If the arm and muscle are 
immobilized the result will be a measurable change in 
the tension of the tendon [4].  
On this approach the method is focused on the 
velocity-dependent increase in the SR Threshold, 
according to the criteria of standard definition of 
spasticity, proposed by Lance [9]. This definition 
suggested that the Stretch Reflex Threshold (SRT) 
depends on the velocity of stretch.  
It is determined the angle of biomechanics range and 
the angular velocity when an increase in 
electromyography activity occurs; it is further processed 
by a custom developed software. Most of the daily life 
activity requires joint angles of 45º for ankle, 140º to full 
flexion to the knee [11] and 150º for elbow [12]. These 
ranges should be considered to ensure the assessment of 
movement in the whole biomechanical range, recruited 
in daily life. The study proposed in [2], where patients 
with stroke are studied, there is detected an increase of 
activity of the EMG (electromyography) signal in Biceps 
Brachia, due to stretching the elbow joint, at angular 
velocities of 51º/s, 161º/s and 430º/s; this demonstrates 
the velocity-dependence of SRT, in muscles affected by 
spasticity.  
To determine the SR Threshold we propose three 
measurements: EMG signal activity in the muscle; 
angular velocity of passive muscle stretch and the joint 
angle position. The angular position and angular velocity 
are measured using an electro-goniometer. The EMG 
signal is recorded using surface Ag/AgCL electrodes 
with bipolar configuration. The EMG and the 
goniometer signals were filtered and sampled with an 
analogical-to-digital converter (ADC) and sent to the 
computer for storage and processing data. 
2.2. Patients 
The patients’ selection was based on the occurrence 
of spasticity symptoms in the flexor muscles in the 
elbow. It was assured, by the clinical assistant that 
patients selected were not under the influence of any 
medicine; this fact could interfere in the results due to 
possible influence in neuromuscular functions. The 
selected patients were aged between 37 and 86 years old. 
All the patients received the necessary information 
regarding the experimental procedure and research 
objective. After reflecting on their participation in the 
study, they signed the Informed Consent. 
2.3. Experimental methodology 
Each patient was evaluated in three consecutive 
sessions, separated by two to five days. In each 
evaluation, it was defined the initial position of the 
elbow joint, the position corresponding to the maximum 
allowable bending of the arm and forearm, with no 
contact between segments. The goniometer was attached 
to the patient member to be assessed. A goniometer arm 
was aligned with the patient's forearm while the other 
goniometer arm was aligned with the patient's arm. 
Then, the surface EMG electrodes were placed in 
correspondence to the motor point of the muscle.  
After checking the initial conditions, it was started the 
process of recording the EMG signals and angular 
displacements, by manually starting stretching the 
muscles. The forearm was extended, by the evaluator, at 
different velocities, from its initial position to the 
maximum extent allowed (specific to each patient). The 
tests promoted ten stretches at “low velocity” (2º/second 
to 150º/second), ten stretches at “moderate velocity” 
(151º/second to 300º/second) and ten stretches at “high 
velocity (higher than 300º/second). 
3. Results 
The time instant at which a SR occurred corresponds 
to the time instant where a sustained increase of the 
EMG activity is verified, two standard deviations (SDs) 
3above the signal average that is observed without 
movement of the patient’s arm. This systematic analysis 
allowed determining, accurately, the corresponding 
values of angle and angular velocity. The DSRT was 
defined considering both: the angle of the joint and the 
value of the angular velocity. For each evaluation, DSRT 
were presented in a graph in two dimensions, 
considering: angular velocity (vertical axis) versus joint 
angle (horizontal axis). Tonic stretch Reflex Threshold 
(TSRT) was estimated by calculating a linear regression 
through the DSRT. The value of TSRT was obtained at 
the point where the regression line intersects the axis 
angle (horizontal axis). Concerning each regression line, 
it was considered the coefficient of determination (R2), 
the inclination of the line, the number of DSRTs and it 
was considered, too, a confidence interval of 95%. In 
this analysis, it was considered significant determination 
coefficient with values equal to or greater than 0.2 and 
negligible determination coefficients with values below 
0.1 [1]. The coefficients between 0.1 and 0.2 are 
considered as minor. 
As expected, SR responds linearly to muscle stretch 
proportionally to stretch velocity. Figure 1 illustrates an 
example of TSRT estimation, for patient M19 (Table 1). 
It can be observed the distribution of 28 DSRTs 
presented as small circles that allowed the calculation of 
the regression line, following the methodology presented 
before. 
It can be stated that the regression line intersects the 
axis corresponding to angular displacement of 124º, 
clearly inside the range of joint movements. In this case, 
the regression line presents a slope of -13,6 and a 
determination coefficient of 0,91. DSRT can be observed 
in all velocities ranges; in particular, at high velocities 
DSRT occurs at lower muscular length. This fact 
presents the obtained results, for all the patients, 
considering the three evaluation sessions.  
The results show satisfactory coefficients of 
determination and a satisfactory variability between 
evaluation sessions. The patients present significant 
determination coefficients comprised between R2=0.33 
and R2=0.9, with exception of patient M15, that only 
present significant determination coefficients during the 
first and second evaluation sessions. The patients M9, 
M3, M18, M4, M6, M14 and M19 show a low variability 
between the evaluation sessions, in the TSRT, and 
standard deviations between ±3.5 and ±13.5. The 
patients M5, M15, M24 e M8 show a high variability 
between the evaluation sessions and standard deviations 
between ±24.09 e ±31.78. 
Considering this last group, the patient M5 has a 
significant determination coefficient during the three 
sessions but shows a high variability; it can be explained 
by the wide discrepancy in the number of observed 
DSRTs, suggesting a lower excitability of the Upper 
Motor Neuron (UMN) in the third evaluation session, 
justifying a higher value of TSRT. Considering patient 
M15, there is a negligible factor in determining the third 
assessment session, R2 = 0.11, originated by the presence 
of false DSRTs, leading to a change in the estimated 
TSRT. Changes in excitability of UMN may be 
associated to emotional stress, discomfort and high 
levels of anxiety related to his participation in the 
experimental tasks [1][2][3]. Low R2 values may be 
associated to the determination of false DSRTs, due to 
the presence of artefacts [1]; and errors of handling the 
goniometer which can cause errors up to 8º [3]. 
Considering, for instance, the measured data, 
corresponding to patient M19 (which results are 
presented in Figure 2), it can be stated that TSRT 
(TSRT=124º) is placed inside the range of normal 
movements of the joint, suggesting that this is the point 
at which a minimum velocity of stretching, close to zero, 
would originate a response of SR. According to the 
model of motor control, “Equilibrium-point”, the value 
of TSRT represents the muscle length from which the 
muscle is fully activated, in response to any stretch, 
registering an increase of torque due to the increase of 
muscle length and of velocity of stretching [12]. The 
area on the right side of the regression line, which 
originates a TSRT, corresponds to the area in which any 
muscular stretch would originate a spastic reaction to the 
movement. In this case, even with slower velocities of 
stretching, the range of movement is limited to 124º of 
amplitude, showing a wide range of movements 
compromised by spasticity. This approach allows 
clinicians to have a clear perception of the range of 
movements compromised by spasticity. Under this 
classification a low value of TSRT, near the beginning of 
the joint range of motion, indicates a high level of 
spasticity, showing a large range of movements 
compromised by spasticity [12]; a high value of TSRT, 
near or above the end of the range of joint movement, 
indicates a low degree of spasticity, showing a small 
range of movement compromised by spasticity. 
Moreover, this study presents the results obtained using 
a medical device, not very complex, easy to use and to 
handle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
figure 1 Example of TSRT estimation 
44. Conclusions and future work 
The objective of the work was to demonstrate and 
validate a dedicated biomedical device developed, 
specially, for quantification of different levels of 
spasticity, based on the velocity-dependent of the SR 
threshold.  
Spasticity quantification has, as main gap, the 
dependence to different parameters related to each 
human being (physiological characteristics), and, also, 
the insufficient reliability of the systems used in its 
determination. This study allows to confirm the 
reliability of the developed system, used for spasticity 
quantification, and to reduce, considerably, possible 
errors, mistakes and/or deviations in its quantification. 
These results are, mainly, consequence of two factors: 
first, the recent technology used concerning the system 
development and, second, the development of a 
dedicated algorithm for muscle activation detection (not 
specified, in detail, in this paper). 
The obtained results show that the proposed 
biomedical system is robust and reliable concerning 
spasticity variability. Nevertheless, we consider relevant, 
as future work, to analyze a larger universe of patients to 
verify the repeatability of the equipment. 
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